Eur Rev Med Pharmacol Sci 2012; 16 (2 Suppl): 79-85 Surgical treatment of tuberculous spondylodiscitis E. Pola, B. Rossi, L.A. Nasto, D. Colangelo, C.A. Logroscino
Eur Rev Med Pharmacol Sci 2012; 16 (2 Suppl): 73-78 Microbiological and immunological diagnosis of tuberculous spondylodiscitis G. Delogu, A. Zumbo, G. Fadda
Eur Rev Med Pharmacol Sci 2012; 16 (2 Suppl): 58-72 Tuberculous spondylodiscitis: epidemiology, clinical features, treatment, and outcome E.M. Trecarichi, E. Di Meco, V. Mazzotta, M. Fantoni
Eur Rev Med Pharmacol Sci 2012; 16 (2 Suppl): 50-57 Post-operative spondylodiscitis L.A. Nasto, D. Colangelo, B. Rossi, M. Fantoni*, E. Pola
Eur Rev Med Pharmacol Sci 2012; 16 (2 Suppl): 35-49 Medical and surgical treatment of pyogenic spondylodiscitis E. Pola, C.A. Logroscino, M. Gentiempo, D. Colangelo, V. Mazzotta*, E. Di Meco*, M. Fantoni*
Eur Rev Med Pharmacol Sci 2012; 16 (2 Suppl): 26-34 Biopsy for suspected spondylodiscitis A. Gasbarrini 1, L. Boriani 1, C. Salvadori 2, S. Mobarec 3, J. Kreshak1, C. Nanni 4, E. Zamparini 2, M. Alberghini 5, P. Viale 2, U. Albisinni 6
Eur Rev Med Pharmacol Sci 2012; 16 (2 Suppl): 20-25 The role of nuclear medicine in the diagnosis of spondylodiscitis G. Treglia, C. Focacci, C. Caldarella, M.V. Mattoli, M. Salsano, S. Taralli, A. Giordano
Eur Rev Med Pharmacol Sci 2012; 16 (2 Suppl): 8-19 Imaging of spondylodiscitis A. Leone, C. Dell’Atti, N. Magarelli, P. Colelli, A. Balanika*, R. Casale, L. Bonomo
Eur Rev Med Pharmacol Sci 2012; 16 (2 Suppl): 2-7 Epidemiological and clinical features of pyogenic spondylodiscitis M. Fantoni, E.M. Trecarichi, B. Rossi*, V. Mazzotta, G. Di Giacomo, L.A. Nasto*, E. Di Meco, E. Pola*
Eur Rev Med Pharmacol Sci 2012; 16 (2 Suppl): 1-1 Pyogenic and Tubercular Spondylodiscitis – Editorial E. Pola, M. Fantoni
